ITERUM THERAPEUTICS PLC (ITRM)
IE000TTOOBX0 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -30.55M | -38.37M | -44.43M | -91.56M | -52.01M | |||
| Depreciation Amortization | 463.00K | 1.75M | 1.80M | 2.10M | 160.00K | |||
| Change In Working Capital | -13.61M | 2.76M | 2.31M | -440.00K | -24.56M | |||
| Interest Paid | N/A | 0.00 | 20.00K | 420.00K | 1.00M | |||
| Taxes Paid | 501.00K | 401.00K | 820.00K | 440.00K | 120.00K | |||
| Other non cash items | 8.34M | -5.47M | 21.85M | 74.06M | 21.87M | |||
| OPERATING CASH FLOW | -35.35M | -39.33M | -18.47M | -15.84M | -54.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -13.00K | -60.00K | -60.00K | -10.00K | |||
| Other Investing Activity | 30.63M | 23.35M | 14.02M | -54.53M | N/A | |||
| INVESTING CASH FLOW | 30.63M | 23.34M | 13.96M | -54.60M | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -2.25M | -6.52M | -5.49M | |||
| Stock Issued/Repurchased | 13.40M | 1.03M | 430.00K | 89.64M | 69.96M | |||
| FINANCING CASH FLOW | 13.40M | 1.03M | -1.82M | 83.13M | 64.48M | |||
| Exchange Rate Effect | -84.00K | -61.00K | -50.00K | 0.00 | -10.00K | |||
| CHANGE IN CASH | 8.59M | -15.02M | -6.38M | 12.69M | 9.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -35.35M | -39.33M | -18.47M | -15.84M | -54.53M | |||
| Capital Expenditure | N/A | -13.00K | -60.00K | -60.00K | -10.00K | |||
| FREE CASH FLOW | -35.36M | -39.34M | -18.53M | -15.90M | -54.54M | |||
All data in USD